These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

609 related items for PubMed ID: 18926421

  • 1. Update on nephrogenic systemic fibrosis.
    Thomsen HS, Marckmann P, Logager VB.
    Magn Reson Imaging Clin N Am; 2008 Nov; 16(4):551-60, vii. PubMed ID: 18926421
    [Abstract] [Full Text] [Related]

  • 2. How to avoid nephrogenic systemic fibrosis: current guidelines in Europe and the United States.
    Thomsen HS.
    Radiol Clin North Am; 2009 Sep; 47(5):871-5, vii. PubMed ID: 19744601
    [Abstract] [Full Text] [Related]

  • 3. Transmetallation and gadolinium: do low iron stores prevent the development of nephrogenic systemic fibrosis in high-risk end-stage renal disease patients?
    Panesar M, Boateng F, Patel SS, Masood SF, Mahajan P, Patel N, Murray B.
    Hemodial Int; 2010 Jul; 14(3):289-94. PubMed ID: 20662951
    [Abstract] [Full Text] [Related]

  • 4. Gadolinium-associated nephrogenic systemic fibrosis.
    Schlaudecker JD, Bernheisel CR.
    Am Fam Physician; 2009 Oct 01; 80(7):711-4. PubMed ID: 19817341
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mechanism of NSF: New evidence challenging the prevailing theory.
    Newton BB, Jimenez SA.
    J Magn Reson Imaging; 2009 Dec 01; 30(6):1277-83. PubMed ID: 19937925
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Nephrogenic systemic fibrosis and its impact on abdominal imaging.
    Prince MR, Zhang HL, Prowda JC, Grossman ME, Silvers DN.
    Radiographics; 2009 Oct 01; 29(6):1565-74. PubMed ID: 19959508
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gadolinium-based contrast agents and nephrogenic systemic fibrosis: why did it happen and what have we learned?
    Weinreb JC, Abu-Alfa AK.
    J Magn Reson Imaging; 2009 Dec 01; 30(6):1236-9. PubMed ID: 19938035
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent.
    Rydahl C, Thomsen HS, Marckmann P.
    Invest Radiol; 2008 Feb 01; 43(2):141-4. PubMed ID: 18197066
    [Abstract] [Full Text] [Related]

  • 15. Nephrogenic systemic fibrosis in advanced chronic kidney disease: a single hospital's experience in Taiwan.
    Chen W, Huang SL, Huang CS, Tsai MC, Lai HM, Lui CC, Eng HL, Chang HW, Lee CH, Chuang FR.
    Eur J Dermatol; 2009 Feb 01; 19(1):44-9. PubMed ID: 19059824
    [Abstract] [Full Text] [Related]

  • 16. Pathomechanisms of nephrogenic systemic fibrosis: new insights.
    Gupta A, Shamseddin MK, Khaira A.
    Clin Exp Dermatol; 2011 Oct 01; 36(7):763-8. PubMed ID: 21790732
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
    Kay J.
    Ann Rheum Dis; 2008 Dec 01; 67 Suppl 3():iii66-9. PubMed ID: 19022818
    [Abstract] [Full Text] [Related]

  • 20. Involvement of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: an update.
    Idée JM, Port M, Dencausse A, Lancelot E, Corot C.
    Radiol Clin North Am; 2009 Sep 01; 47(5):855-69, vii. PubMed ID: 19744600
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.